|
|
PART I – FINANCIAL INFORMATION
Item 1. Condensed Consolidated Financial Statements
LANCASTER COLONY CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(UNAUDITED)
| | | | | | | | | | | |
| (Amounts in thousands, except share data) | September 30, 2024 | | June 30, 2024 |
| ASSETS |
| Current Assets: | | | |
| Cash and equivalents | $ | | | | $ | | |
| Receivables | | | | | |
| Inventories: | | | |
| Raw materials | | | | | |
| Finished goods | | | | | |
| Total inventories | | | | | |
| Other current assets | | | | | |
| Total current assets | | | | | |
| Property, Plant and Equipment: | | | |
|
|
| Property, plant and equipment-gross | | | | | |
| Less accumulated depreciation | | | | | |
| Property, plant and equipment-net | | | | | |
| Other Assets: | | | |
| Goodwill | | | | | |
|
|
|
| | | |
| | | | |
| | | | |
| | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | $ | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
|
|
| | | | |
| | | | |
|
|
|
| 2023 |
|
|
)
))| | | | $ | | |
See accompanying notes to condensed consolidated financial statements.
LANCASTER COLONY CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
| | | | | | | | | | | |
| Three Months Ended September 30, |
| (Amounts in thousands) | 2024 | | 2023 |
| Cash Flows From Operating Activities: | | | |
| Net income | $ | | | | $ | | |
| Adjustments to reconcile net income to net cash provided by operating activities: | | | |
| Impacts of noncash items: | | | |
| Depreciation and amortization | | | | | |
|
| Deferred income taxes and other changes | | | | | |
| Stock-based compensation expense | | | | | |
|
|
|
| Pension plan activity | | | | () | |
| Changes in operating assets and liabilities: | | | |
| Receivables | () | | | () | |
| Inventories | () | | | () | |
| Other current assets | () | | | () | |
| Accounts payable and accrued liabilities | () | | | () | |
| Net cash provided by operating activities | | | | | |
| Cash Flows From Investing Activities: | | | |
| Payments for property additions | () | | | () | |
|
|
|
| Other-net | () | | | () | |
| Net cash used in investing activities | () | | | () | |
| Cash Flows From Financing Activities: | | | |
| Payment of dividends | () | | | () | |
| Purchase of treasury stock | () | | | () | |
| Tax withholdings for stock-based compensation | () | | | | |
|
| Principal payments for finance leases | () | | | () | |
| Net cash used in financing activities | () | | | () | |
|
|
|
|
| Net change in cash and equivalents | () | | | () | |
| Cash and equivalents at beginning of year | | | | | |
| Cash and equivalents at end of period | $ | | | | $ | | |
| Supplemental Disclosure of Operating Cash Flows: | | | |
| Net cash payments for income taxes | $ | | | | $ | | |
|
|
See accompanying notes to condensed consolidated financial statements.
LANCASTER COLONY CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY
(UNAUDITED)
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended September 30, 2024 |
(Amounts in thousands, except per share data) | | Common Stock Outstanding | | Retained Earnings | | Accumulated Other Comprehensive Loss | | Treasury Stock | | Total Shareholders’ Equity |
| Shares | | Amount | | | | | | | | |
| Balance, June 30, 2024 | | | | | $ | | | | $ | | | | $ | () | | | $ | () | | | $ | | |
| Net income | | | | | | | | | | | | | | |
Net pension and postretirement benefit gains, net of $ tax effect | | | | | | | | | | | | | | |
Cash dividends - common stock ($ per share) | | | | | | () | | | | | | | () | |
| Purchase of treasury stock | | () | | | | | | | | | () | | | () | |
| Stock-based plans | | | | | () | | | | | | | | | () | |
| Stock-based compensation expense | | | | | | | | | | | | | | |
| Balance, September 30, 2024 | | | | | $ | | | | $ | | | | $ | () | | | $ | () | | | $ | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended September 30, 2023 |
(Amounts in thousands, except per share data) | | Common Stock Outstanding | | Retained Earnings | | Accumulated Other Comprehensive Loss | | Treasury Stock | | Total Shareholders’ Equity |
| Shares | | Amount | | | | | | | | |
| Balance, June 30, 2023 | | | | | $ | | | | $ | | | | $ | () | | | $ | () | | | $ | | |
| Net income | | | | | | | | | | | | | | |
Net pension and postretirement benefit gains, net of $ tax effect | | | | | | | | | | | | | | |
Cash dividends - common stock ($ per share) | | | | | | () | | | | | | | () | |
| Purchase of treasury stock | | () | | | | | | | | | () | | | () | |
| Stock-based plans | | | | | | | | | | | | | | | |
| Stock-based compensation expense | | | | | | | | | | | | | | |
| Balance, September 30, 2023 | | | | | $ | | | | $ | | | | $ | () | | | $ | () | | | $ | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
|
)
|
|
|
|
|
|
))) | | | |
| | | | |
| () | | | $ | () | |
Significant Accounting Policies
There were no changes to our Significant Accounting Policies from those disclosed in our 2024 Annual Report on Form 10-K.
LANCASTER COLONY CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share data)
Note 2 –
million at any one time, with potential to expand the total credit availability to $ million based on consent of the issuing banks and certain other conditions. The Facility expires on , and all outstanding amounts are then due and payable. Interest is variable based upon formulas tied to SOFR or an alternate base rate defined in the Facility. We must also pay facility fees that are tied to our then-applicable consolidated leverage ratio. Loans may be used for general corporate purposes. Due to the nature of its terms, when we have outstanding borrowings under the Facility, they will be classified as long-term debt.The Facility contains certain restrictive covenants, including limitations on indebtedness, asset sales and acquisitions. There are two principal financial covenants: an interest expense test that requires us to maintain an interest coverage ratio not less than to 1 at the end of each fiscal quarter; and an indebtedness test that requires us to maintain a consolidated leverage ratio not greater than to 1, subject to certain exceptions. The interest coverage ratio is calculated by dividing Consolidated EBIT by Consolidated Interest Expense, and the leverage ratio is calculated by dividing Consolidated Net Debt by Consolidated EBITDA. All financial terms used in the covenant calculations are defined more specifically in the Facility.
At September 30, 2024 and June 30, 2024, we had borrowings outstanding under the Facility. At September 30, 2024 and June 30, 2024, we had $ million and $ million, respectively, of standby letters of credit outstanding, which reduced the amount available for borrowing under the Facility. We paid interest for the three months ended September 30, 2024 and 2023.
Note 3 –
Note 4 –
million and $ million, respectively, at September 30, 2024 and June 30, 2024. |
| | | | |
| | | | | Note 5 –
million and $ million were included in Other Current Assets at September 30, 2024 and June 30, 2024, respectively. Accrued state and local income taxes of $ million and $ million were included in Accrued Liabilities at September 30, 2024 and June 30, 2024, respectively.
LANCASTER COLONY CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share data)
Note 6 –
|
| | | | |
)
|
|
|
| | | |
| | | | |
|
|
|
| | | |
| | | | |
| | 51,947 | | | 3,013 | | | 5.8 | % |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
|
| | | | | | | | |
| | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
|
| % | | 12.1 | % | | | | |
For the three months ended September 30, 2024, Foodservice segment net sales grew 3.5% to $227.0 million compared to $219.4 million in the prior-year period driven by increased demand from several of our national chain restaurant account customers and growth for our Marzetti® branded Foodservice products. Foodservice segment sales volumes, measured in pounds shipped, increased 3.1%.
For the three months ended September 30, 2024, Foodservice segment operating income decreased 8.7% to $24.3 million driven by higher supply chain costs, investments in customer programs, and increased brokerage expenses, as partially offset by the beneficial impact of the higher sales volumes.
Corporate Expenses
For the three months ended September 30, 2024 and 2023, corporate expenses totaled $24.6 million and $23.0 million, respectively. This increase primarily reflects investments in personnel, as well as higher legal expenses.
LOOKING FORWARD
Looking forward to our fiscal second quarter and the remainder of our fiscal year, we anticipate Retail segment sales will continue to benefit from our growing licensing program, driven by our new product introductions, including Subway sauces and Texas Roadhouse dinner rolls. Our newly launched New York BRAND® Bakery gluten-free garlic bread will also add to the Retail segment’s sales. In the Foodservice segment, we anticipate continued volume gains from select quick-service restaurant customers in our mix of national chain restaurant accounts, while external factors, including U.S. economic performance and consumer behavior, will likely impact demand. With respect to our input costs, in aggregate we do not foresee significant impacts from commodity cost inflation or deflation.
We will continue to periodically reassess our allocation of capital to ensure that we maintain adequate operating flexibility while providing appropriate levels of cash returns to our shareholders.
FINANCIAL CONDITION
Cash Flows
For the three months ended September 30, 2024, net cash provided by operating activities totaled $19.9 million, as compared to $35.6 million in the prior-year period. This decrease was primarily due to the year-over-year changes in net working capital, particularly accounts payable and other current assets. The current-year period reflected the unfavorable cash flow impacts of both lower accounts payable and higher prepaid federal income taxes while the prior-year period benefited from an increase in accounts payable. Changes in accounts payable were impacted by the timing of payments.
Cash used in investing activities for the three months ended September 30, 2024 of $19.9 million was comparable to $19.7 million in the prior year.
Cash used in financing activities for the three months ended September 30, 2024 of $28.4 million decreased from the prior-year total of $30.6 million. This decrease reflects lower levels of share repurchases, as partially offset by higher tax withholdings for stock-based compensation and higher dividend payments.
Liquidity and Capital Resources
Under our unsecured revolving credit facility (“Facility”), we may borrow up to a maximum of $150 million at any one time. We had no borrowings outstanding under the Facility at September 30, 2024. At September 30, 2024, we had $2.6 million of standby letters of credit outstanding, which reduced the amount available for borrowing under the Facility. The Facility expires in March 2029, and all outstanding amounts are then due and payable. Interest is variable based upon formulas tied to SOFR or an alternate base rate defined in the Facility. We must also pay facility fees that are tied to our then-applicable consolidated leverage ratio. Loans may be used for general corporate purposes. Due to the nature of its terms, when we have outstanding borrowings under the Facility, they will be classified as long-term debt.
The Facility contains certain restrictive covenants, including limitations on liens, asset sales and acquisitions, and financial covenants relating to interest coverage and leverage. At September 30, 2024, we were in compliance with all applicable provisions and covenants of this facility, and we exceeded the requirements of the financial covenants by substantial margins. At September 30, 2024, there were no events that would constitute a default under this facility.
We currently expect to remain in compliance with the Facility’s covenants for the foreseeable future. However, a default under the Facility could accelerate the repayment of any then outstanding indebtedness and limit our access to $75 million of additional credit available under the Facility. Such an event could require a reduction in or curtailment of cash dividends or share repurchases, reduce or delay beneficial expansion or investment plans, or otherwise impact our ability to meet our obligations when due.
We believe that cash provided by operating activities and our existing balances in cash and equivalents, in addition to that available under the Facility, should be adequate to meet our liquidity needs over the next 12 months, including the projected levels of capital expenditures and dividend payments. If we were to borrow outside of the Facility under current market terms, our average interest rate may increase and have an adverse effect on our results of operations. Based on our current plans and expectations, we believe our capital expenditures for 2025 could total between $70 and $80 million.
Beyond the next 12 months, we expect that cash provided by operating activities will be the primary source of liquidity. This source, combined with our existing balances in cash and equivalents and amounts available under the Facility, is expected to be sufficient to meet our overall cash requirements.
We have various contractual and other obligations that are appropriately recorded as liabilities in our condensed consolidated financial statements. Certain other contractual obligations are not recognized as liabilities in our condensed consolidated financial statements. Examples of such obligations are commitments to purchase raw materials or packaging inventory that has not yet been received as of September 30, 2024 and purchase orders and longer-term purchase arrangements related to the procurement of services, including IT service agreements, and property, plant and equipment. The majority of these obligations is expected to be due within one year.
CRITICAL ACCOUNTING POLICIES
There have been no changes in critical accounting policies from those policies disclosed in our 2024 Annual Report on Form 10-K.
RECENT ACCOUNTING PRONOUNCEMENTS
Recent accounting pronouncements and their impact on our consolidated financial statements are disclosed in Note 1 to the condensed consolidated financial statements.
FORWARD-LOOKING STATEMENTS
We desire to take advantage of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 (the “PSLRA”). This Quarterly Report on Form 10-Q contains various “forward-looking statements” within the meaning of the PSLRA and other applicable securities laws. Such statements can be identified by the use of the forward-looking words “anticipate,” “estimate,” “project,” “believe,” “intend,” “plan,” “expect,” “hope” or similar words. These statements discuss future expectations; contain projections regarding future developments, operations or financial conditions; or state other forward-looking information. Such statements are based upon assumptions and assessments made by us in light of our experience and perception of historical trends, current conditions, expected future developments and other factors we believe to be appropriate. These forward-looking statements involve various important risks, uncertainties and other factors that could cause our actual results to differ materially from those expressed in the forward-looking statements. Actual results may differ as a result of factors over which we have no, or limited, control including, without limitation, the specific influences outlined below. Management believes these forward-looking statements to be reasonable; however, one should not place undue reliance on such statements that are based on current expectations. Forward-looking statements speak only as of the date they are made, and we undertake no obligation to update such forward-looking statements, except as required by law.
Items which could impact these forward-looking statements include, but are not limited to:
•efficiencies in plant operations and our overall supply chain network;
•price and product competition;
•changes in demand for our products, which may result from changes in consumer behavior or loss of brand reputation or customer goodwill;
•the impact of customer store brands on our branded retail volumes;
•the impact of any regulatory matters affecting our food business, including any additional requirements imposed by the FDA or any state or local government;
•adequate supply of labor for our manufacturing facilities;
•stability of labor relations;
•adverse changes in freight, energy or other costs of producing, distributing or transporting our products;
•the reaction of customers or consumers to pricing actions we take to offset inflationary costs;
•inflationary pressures resulting in higher input costs;
•fluctuations in the cost and availability of ingredients and packaging;
•capacity constraints that may affect our ability to meet demand or may increase our costs;
•dependence on contract manufacturers, distributors and freight transporters, including their operational capacity and financial strength in continuing to support our business;
•dependence on key personnel and changes in key personnel;
•cyber-security incidents, information technology disruptions, and data breaches;
•the potential for loss of larger programs or key customer relationships;
•failure to maintain or renew license agreements;
•geopolitical events that could create unforeseen business disruptions and impact the cost or availability of raw materials and energy;
•the possible occurrence of product recalls or other defective or mislabeled product costs;
•the success and cost of new product development efforts;
•the lack of market acceptance of new products;
•the extent to which good-fitting business acquisitions are identified, acceptably integrated, and achieve operational and financial performance objectives;
•the effect of consolidation of customers within key market channels;
•maintenance of competitive position with respect to other manufacturers;
•the outcome of any litigation or arbitration;
•significant shifts in consumer demand and disruptions to our employees, communities, customers, supply chains, production planning, operations, and production processes resulting from the impacts of epidemics, pandemics or similar widespread public health concerns and disease outbreaks;
•changes in estimates in critical accounting judgments;
•the impact of fluctuations in our pension plan asset values on funding levels, contributions required and benefit costs; and
•certain other factors, including the information disclosed in our discussion of risk factors under Item 1A of our 2024 Annual Report on Form 10-K.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
Our market risks have not changed materially from those disclosed in our 2024 Annual Report on Form 10-K.
Item 4. Controls and Procedures
(a) Evaluation of Disclosure Controls and Procedures. As of the end of the period covered by this Quarterly Report on Form 10-Q, our management, including our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)). Based upon this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of September 30, 2024 to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act is 1) recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and 2) accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, in a manner that allows timely decisions regarding required disclosure.
(b) Changes in Internal Control Over Financial Reporting. No changes were made to our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) during our most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
PART II – OTHER INFORMATION
Item 1. Legal Proceedings
We are required to disclose certain environmental matters when a governmental authority is a party to the proceedings and such proceedings involve potential monetary sanctions that we reasonably believe will be in excess of an applied threshold not to exceed $1 million. We are using a threshold of $1 million as we believe this amount is reasonably designed to result in disclosure of such proceedings that are material to our business or financial condition. Applying this threshold, there are no environmental matters to disclose in this Form 10-Q.
Item 1A. Risk Factors
There have been no material changes to the risk factors disclosed under Item 1A in our 2024 Annual Report on Form 10-K.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
(c) In November 2010, our Board of Directors approved a share repurchase authorization of 2,000,000 common shares, of which 1,124,291 common shares remained authorized for future repurchases at September 30, 2024. This share repurchase authorization does not have a stated expiration date. In the first quarter, we made the following repurchases of our common stock:
| | | | | | | | | | | | | | | | | | | | | | | |
| Period | Total Number of Shares Purchased | | Average Price Paid Per Share | | Total Number of Shares Purchased as Part of Publicly Announced Plans | | Maximum Number of Shares that May Yet be Purchased Under the Plans |
| July 1-31, 2024 | — | | | $ | — | | | — | | | 1,131,564 | |
August 1-31, 2024(1) | 7,257 | | | $ | 198.02 | | | 7,257 | | | 1,124,307 | |
September 1-30, 2024(1) | 16 | | | $ | 181.11 | | | 16 | | | 1,124,291 | |
| Total | 7,273 | | | $ | 197.98 | | | 7,273 | | | 1,124,291 | |
(1)Represents shares that were repurchased in satisfaction of tax withholding obligations arising from the vesting of restricted stock granted to employees under the Lancaster Colony Corporation 2015 Omnibus Incentive Plan.
Item 6. Exhibits
See Index to Exhibits below.
INDEX TO EXHIBITS
| | | | | | | | |
| Exhibit Number | | Description |
| | |
| | |
| |
| | |
| |
| | |
| |
101.INS(a) | | XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document |
| |
101.SCH(a) | | Inline XBRL Taxonomy Extension Schema Document |
| |
101.CAL(a) | | Inline XBRL Taxonomy Extension Calculation Linkbase Document |
| |
101.DEF(a) | | Inline XBRL Taxonomy Extension Definition Linkbase Document |
| |
101.LAB(a) | | Inline XBRL Taxonomy Extension Label Linkbase Document |
| |
101.PRE(a) | | Inline XBRL Taxonomy Extension Presentation Linkbase Document |
| | |
104(a) | | The cover page of Lancaster Colony Corporation’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2024, formatted in Inline XBRL (included within Exhibit 101 attachments) |
| | |
| (a) | | Filed herewith |
| | |
| (b) | | Furnished herewith |
|
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| | | | | | | | | | | | | | | | | |
| | | | | |
| | | LANCASTER COLONY CORPORATION |
| | | | | (Registrant) |
| Date: | October 31, 2024 | | By: | | /s/ DAVID A. CIESINSKI |
| | | | | David A. Ciesinski |
| | | | | President, Chief Executive Officer |
| | | | | and Director |
| | | | | (Principal Executive Officer) |
| | | | | |
| Date: | October 31, 2024 | | By: | | /s/ THOMAS K. PIGOTT |
| | | | | Thomas K. Pigott |
| | | | | Vice President, Chief Financial Officer |
| | | | | and Assistant Secretary |
| | | | | (Principal Financial and Accounting Officer) |
Similar companies
See also Kraft Heinz Co -
Annual report 2022 (10-K 2022-12-31)
Annual report 2023 (10-Q 2023-09-30)
See also Lamb Weston Holdings, Inc. -
Annual report 2023 (10-K 2023-05-28)
Annual report 2023 (10-Q 2023-08-27)
See also TreeHouse Foods, Inc. -
Annual report 2022 (10-K 2022-12-31)
Annual report 2023 (10-Q 2023-09-30)
See also BARFRESH FOOD GROUP INC. -
Annual report 2022 (10-K 2022-12-31)
Annual report 2023 (10-Q 2023-09-30)
See also Planet Green Holdings Corp. -
Annual report 2022 (10-K 2022-12-31)
Annual report 2023 (10-Q 2023-09-30)